Today: 25 January 2026
Subscribe
Browse Category

IPOs News 6 November 2025 - 2 December 2025

Nasdaq Nordic Stock Market Today, 2 December 2025: OMXS30, OMXC25 and OMXH25 Edge Higher as Deals, Buybacks and IPOs Drive Action

Nasdaq Nordic Stock Market Today, 2 December 2025: OMXS30, OMXC25 and OMXH25 Edge Higher as Deals, Buybacks and IPOs Drive Action

Nordic equities opened the first full trading week of December on a cautiously positive note. After a weak global start to the month, the main Nasdaq Nordic benchmarks in Stockholm, Copenhagen and Helsinki all traded modestly higher on Tuesday, while a busy slate of buybacks, bond issues, conversions and a high‑profile IPO reshaped the regional corporate landscape. InvestmentNews Nordic benchmarks:…
2 December 2025
··
Prudential plc (PRU) Rallies on Fresh Buybacks as ICICI Prudential AMC IPO Wins SEBI Approval – 27 November 2025

Prudential plc (PRU) Rallies on Fresh Buybacks as ICICI Prudential AMC IPO Wins SEBI Approval – 27 November 2025

Prudential’s share price pushes higher after another round of buybacks and a key green light for its Indian asset-management joint venture. Prudential Share Price Today: PRU Near Highs After Technical Breakout Prudential plc’s London‑listed shares (LSE: PRU) finished Thursday’s session at 1,093.5p, with a quoted spread of 1,093.5p (sell) to 1,094.0p (buy), up 12.5p on the day — a gain…
27 November 2025
····
Fed-Cut Hopes Keep Hong Kong Stocks Afloat as Quantgroup IPO Soars and Property Fears Linger

Fed-Cut Hopes Keep Hong Kong Stocks Afloat as Quantgroup IPO Soars and Property Fears Linger

Hong Kong’s stock market ended Thursday, 27 November 2025, essentially flat but still in the green, as optimism over imminent U.S. interest-rate cuts balanced fresh signs of China’s slowing industrial profits and renewed stress in the property and insurance sectors. The Hang Seng Index closed at 25,945.93, up about 0.07% (17.85 points), marking a fourth straight session of gains and…
27 November 2025
···
US IPO Market 2025: Shutdown Backlog, SEC Deregulation and a Narrow December IPO Window

US IPO Market 2025: Shutdown Backlog, SEC Deregulation and a Narrow December IPO Window

November 26, 2025 After a red‑hot first three quarters, the US IPO market is ending 2025 in a far more fragile mood. A record‑length government shutdown has left the Securities and Exchange Commission (SEC) digging through an “epic” filing backlog, volatility has cut IPO returns to single digits, and the December equity capital markets (ECM) window is suddenly looking very…
26 November 2025
···
WeShop Holdings (NASDAQ: WSHP) Soars Again as Nasdaq Composite Adds New Social‑Commerce Stock – 17 November 2025 Update

WeShop Holdings (WSHP) Soars Nearly 600% on Nasdaq as Trading Halts Mark Wild Post‑Listing Rally – 19 November 2025

LONDON / NEW YORK – 19 November 2025 – Newly listed social‑commerce stock WeShop Holdings Limited (NASDAQ: WSHP) staged one of the wildest moves on Wall Street today, rocketing from a modest pre‑market gain to a late‑session surge of almost 600% and triggering a string of volatility‑related trading halts along the way.  Benzinga The explosive action comes just days after WeShop’s direct listing on Nasdaq and reflects intense…
19 November 2025
··
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Indian Stock Market Today, 18 November 2025: Sensex, Nifty Break Winning Streak as New-Age IPOs Steal the Show

The Indian stock market paused for breath on Tuesday, 18 November 2025, as benchmark indices snapped a six-session winning streak amid a global tech-led sell-off and profit booking in key heavyweights. At the same time, Dalal Street’s obsession with new-age listings – PhysicsWallah, Emmvee Photovoltaic and Capillary Technologies – stayed front and centre. Sensex and Nifty Today: How Dalal Street…
18 November 2025
····
How to Buy SpaceX Stock in 2025: Latest Valuation, IPO Signals and Who Really Owns the Shares (Updated 14 November 2025)

How to Buy SpaceX Stock in 2025: Latest Valuation, IPO Signals and Who Really Owns the Shares (Updated 14 November 2025)

SpaceX remains the private company many retail investors dream of owning. Elon Musk’s rocket and satellite giant is helping launch NASA missions, blanketing the planet with Starlink internet – and, as of mid‑2025, it’s reportedly being valued around $400 billion in insider share sales. TechCrunch Yet as of 14 November 2025, there is still no public SpaceX stock you can…
14 November 2025
····
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

CYPH Debuts: Cypherpunk Technologies (ex‑Leap Therapeutics) starts trading, files $200M ATM, posts Q3 results and details $50M Zcash treasury — 13 Nov 2025

Published: November 13, 2025 Cypherpunk Technologies Inc. — the newly renamed Leap Therapeutics — began trading on the Nasdaq this morning under the ticker CYPH, marking the company’s formal pivot from oncology biotech to a “digital‑asset treasury” strategy centered on Zcash (ZEC). Options symbols and identifiers also updated in step with the change. PR Newswire What changed today The strategy…
13 November 2025
···
Germany’s Submarine Builder TKMS Debuts Amid Defense Boom – Is It the Next Rheinmetall?

TKMS Stock Jumps 4% on Nov 10, 2025: Why Thyssenkrupp Marine Systems Is Rebounding After a Volatile Post‑IPO Start

FRANKFURT — November 10, 2025. Shares of Thyssenkrupp Marine Systems (TKMS) rebounded sharply on Monday, rising about 4% intraday to ~€73.95 and trimming losses from a rough first full week of trading after October’s blockbuster listing. The move follows a string of weaker sessions that left the stock down double digits week‑over‑week. Wallstreet Online Key takeaways (Nov 10, 2025) Today’s…
10 November 2025
····
Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive, Inc. (Nasdaq: ASST)—the parent of Strive Asset Management, LLC—priced an upsized initial public offering of its Variable Rate Series A Perpetual Preferred Stock (“SATA Stock”) at $80 per share, expanding the deal to 2,000,000 shares for ~$160 million in expected gross proceeds. Settlement is slated for Monday, November 10, 2025, pending customary closing conditions. The preferred carries an initial…
6 November 2025
···
Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

MUMBAI | Thursday, November 6, 2025 — Packaged‑foods maker Orkla India made a muted stock‑market debut on Thursday, listing at a modest premium to the IPO price before giving up gains during the session. The stock opened at ₹750.10 on the NSE and ₹751.50 on the BSE vs an issue price of ₹730, but later slipped below the IPO price,…
6 November 2025
····
WeRide (0800.HK) and Pony.ai (2026.HK) sink on Hong Kong debut as IPO wave tests robotaxi stocks

WeRide (0800.HK) and Pony.ai (2026.HK) sink on Hong Kong debut as IPO wave tests robotaxi stocks

Nov 6, 2025 — Hong Kong Chinese robotaxi developers WeRide and Pony.ai stumbled out of the gate in Hong Kong on Thursday, with both stocks sliding around 10% in early dealings despite raising a combined ~HK$9.1 billion (US$1.17 billion) in fresh capital. The weak start comes amid a rush of new listings and lingering doubts about the near‑term profitability of…
6 November 2025
····
1 2 3 4 5

Stock Market Today

  • BillionToOne (BLLN) Shares Pull Back Amid Growth Prospects and Valuation Debate
    January 25, 2026, 7:59 AM EST. BillionToOne (BLLN) shares slipped 3.3% in one day, trading near $87.57, down 1.93% year-to-date. The diagnostics company shows 22.88% annual revenue growth but trades at a 45.31% discount to a $135.29 fair value estimate. Growth in noninvasive prenatal testing and a key Johnson & Johnson diagnostic partnership support optimism. However, increased competition in prenatal testing and potential reimbursement cuts pose risks. Investors are weighing whether the sell-off highlights a buying opportunity or reflects market caution about future growth. The firm's valuation rests on assumptions of revenue expansion, margin improvement, and evolving earnings.
Go toTop